NEUROSURGERY / LETTER TO THE EDITOR
 
TOPICS
REFERENCES (17)
1.
Casar-Borota O, Burman P, Lopes MB. The 2022 WHO classification of tumors of the pituitary gland: an update on aggressive and metastatic pituitary neuroendocrine tumors. Brain Pathol 2025; 35: e13302.
 
2.
Tritos NA, Miller KK. Diagnosis and management of pituitary adenomas: a review. JAMA 2023; 329: 1386-98.
 
3.
Meher D, Agarwal V, Das S, et al. Pituitary apoplexy: a case series. Cureus 2025; 17: e97380.
 
4.
Bonneville JF, Potorac J, Beckers A. Neuroimaging of aggressive pituitary tumors. Revn Endocr Metab Disord 2020; 21: 235-42.
 
5.
Patel V, Liu CSJ, Shiroishi MS, et al. Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas. Neuroradiology 2020; 62: 1051-4.
 
6.
Zhu HJ. Current status and challenges in the treatment of refractory pituitary prolactinomas. Chin Med J 2025; 105: 3738-42.
 
7.
Shimon I, Melmed S. Management of pituitary tumors. Ann Intern Med 1998; 129: 472-83.
 
8.
Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 1998; 83: 2646-52.
 
9.
Marquez Y, Tuchman A, Zada G. Surgery and radiosurgery for acromegaly: a review of indications, operative techniques, outcomes, and complications. Int J Endocrinol 2012; 2012: 386401.
 
10.
Colao A, Auriemma RS, Pivonello R. The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary 2016; 19: 210-21.
 
11.
Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol 2006; 17: 1733-42.
 
12.
Theodoropoulou M, Stalla GK. Somatostatin receptors: from signaling to clinical practice. Front Neuroendocrinol 2013; 34: 228-52.
 
13.
Caron PJ, Bevan JS, Petersenn S, et al. Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial. J Clin Endocrinol Metab 2014; 99: 1282-90.
 
14.
Albarel F, Castinetti F, Morange I, et al. Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly. Pituitary 2018; 21: 615-23.
 
15.
Acitores Cancela A, Rodríguez Berrocal V, Pian H, et al. Clinical relevance of tumor consistency in pituitary adenoma. Hormones 2021; 20: 463-73.
 
16.
Lin AL, Donoghue MTA, Wardlaw SL, et al. Approach to the treatment of a patient with an aggressive pituitary tumor. J Clin Endocrinol Metab 2020; 105: 3807-20.
 
17.
Ding H, Wu X, Wu BW, et al. Further investigation of the lateral approach for the resection of Knosp grade 4 pituitary adenomas in endoscopic endonasal surgery. J Neurosurg 2024; 141: 184-94.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top